AE
Insider
Andrea Ellis
DirectorAndrea Ellis (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $4.2M of BBIO (64,921 sh × $64.87, as filed), executed Mar 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.7M
shares × price, as filed
Last traded
Jul 9
Filed Jul 13
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$1.4M17,167 sh × $84.00
Exec Jul 9
Filed Jul 13 · 4:41 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $4.2M
64,921 sh × $64.87
Exec Mar 4
Filed Mar 6 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $841K
17,167 sh × $49.00
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $350K
10,000 sh × $35.00
Exec Apr 14 2025
Filed Apr 16 2025 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.0M
30,000 sh × $34.05
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET